The role of lipids in Parkinson's disease
H Xicoy, B Wieringa, GJM Martens - Cells, 2019 - mdpi.com
Parkinson's disease (PD) is a neurodegenerative disease characterized by a progressive
loss of dopaminergic neurons from the nigrostriatal pathway, formation of Lewy bodies, and …
loss of dopaminergic neurons from the nigrostriatal pathway, formation of Lewy bodies, and …
[HTML][HTML] Update on statin treatment in patients with neuropsychiatric disorders
Statins are widely accepted as first-choice agents for the prevention of lipid-related
cardiovascular diseases. These drugs have both anti-inflammatory and anti-oxidant …
cardiovascular diseases. These drugs have both anti-inflammatory and anti-oxidant …
Effects of statins on dopamine loss and prognosis in Parkinson's disease
Statins are more widely used not only for the primary and secondary prevention of
cardiovascular disease by blocking cholesterol biosynthesis but also for the potential …
cardiovascular disease by blocking cholesterol biosynthesis but also for the potential …
Association of hydroxylmethyl glutaryl coenzyme A reductase inhibitors, L-type calcium channel antagonists, and biguanides with rates of psychiatric hospitalization …
Importance Drug repurposing is potentially cost-effective, low risk, and necessary in
psychiatric drug development. The availability of large, routine data sets provides the …
psychiatric drug development. The availability of large, routine data sets provides the …
Adjunctive therapy with statins in schizophrenia patients: a meta-analysis and implications
H Shen, R Li, R Yan, X Zhou, X Feng, M Zhao… - Psychiatry Research, 2018 - Elsevier
There are some conflicting results regarding the benefit of adjunctive therapy with statins for
severity of negative symptoms in schizophrenia. This study aimed to verify whether statins …
severity of negative symptoms in schizophrenia. This study aimed to verify whether statins …
Cholesterol–a putative endogenous contributor towards Parkinson's disease
R Paul, A Choudhury, A Borah - Neurochemistry international, 2015 - Elsevier
Elevated levels of cholesterol and its metabolites (oxysterols) have been reported to be
associated not only with several metabolic syndromes, but also become a prognostic risk …
associated not only with several metabolic syndromes, but also become a prognostic risk …
High dose of simvastatin induces hyperlocomotive and anxiolytic-like activities: The association with the up-regulation of NMDA receptor binding in the rat brain
Statins are widely being used for the treatment of a variety of conditions beyond their original
indication for lowering cholesterol. We have previously reported that simvastatin affected the …
indication for lowering cholesterol. We have previously reported that simvastatin affected the …
[HTML][HTML] The Potential Therapeutic Application of Simvastatin for Brain Complications and Mechanisms of Action
YM Vuu, A Kadar Shahib, M Rastegar - Pharmaceuticals, 2023 - mdpi.com
Statins are common drugs that are clinically used to reduce elevated plasma cholesterol
levels. Based on their solubility, statins are considered to be either hydrophilic or lipophilic …
levels. Based on their solubility, statins are considered to be either hydrophilic or lipophilic …
Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management
M Tuccori, S Montagnani, S Mantarro… - Cns Drugs, 2014 - Springer
Abstract Statins, or 3-hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, such as
lovastatin, atorvastatin, simvastatin, pravastatin, fluvastatin, rosuvastatin and pitavastatin, are …
lovastatin, atorvastatin, simvastatin, pravastatin, fluvastatin, rosuvastatin and pitavastatin, are …
Statin therapy prevents the onset of Parkinson disease in patients with diabetes
KD Lin, CY Yang, MY Lee, SC Ho, CK Liu… - Annals of …, 2016 - Wiley Online Library
Objective We studied the association between the statin dosage and the risk of Parkinson
disease (PD) in diabetic patients in Taiwan. Methods One million patients were randomly …
disease (PD) in diabetic patients in Taiwan. Methods One million patients were randomly …